6505--Nicotine Lozenges MINI (VA-26-00020754)
ID: 36E79726R0007Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/f20d17c569214fb692952f082c61d1aa/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the supply of Nicotine Polacrilex Mini Lozenges under solicitation number 36E79726R0007. This contract aims to establish a reliable source for the provision of these lozenges to various federal facilities, including those under the VA, DoD, IHS, and BOP, through Pharmaceutical Prime Vendor (PPV) Programs. The selected offeror will be required to comply with stringent requirements, including FDA product registration, adherence to packaging and barcoding standards, and maintaining acceptable cGMP status for manufacturing. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details, and proposals must include pricing for a base year and four option years for both 2mg and 4mg lozenges.

    Point(s) of Contact
    Billy FongContract Specialist
    Billy.Fong@va.gov
    Files
    Title
    Posted
    36E79726R0007_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center plans to issue an unrestricted Request for Proposal (RFP) 36E79726R0007 for Nicotine Mini Lozenges. This contract will supply the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS) with an uninterrupted source of nicotine mini lozenges. The contract will be for one year with four one-year option periods, distributing items through the VA and DOD Pharmaceutical Prime Vendor Programs. Offerors must provide the exact drug name and a unique NDC number. The solicitation will be issued electronically around December 18, 2025, with a tentative closing date of January 1, 2026, on sam.gov. The NAICS code for this procurement is 325412. Estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges. Billy Fong is the point of contact for inquiries.
    36E79726R0007.docx
    This government solicitation, 36E79726R0007, from the Department of Veterans Affairs, outlines a contract for Nicotine Polacrilex Mini Lozenges. The contract establishes a supply source for VA, DoD, IHS, and BOP facilities through Pharmaceutical Prime Vendor (PPV) Programs. It details requirements for pricing, including a 0.5% Cost Recovery Fee, and mandates that offerors propose prices for a base year and four option years for both 2mg and 4mg lozenges. Key provisions cover product registration with FDA, First Databank, Medispan, and Cerner Multum, as well as strict packaging and barcoding standards, including DSCSA compliance. Offerors must also provide unique 11-digit NDC/UPC numbers and hold an FDA-approved drug application. The document emphasizes the importance of maintaining an acceptable cGMP status for manufacturing facilities and outlines procedures for handling backorders and product recalls. It also addresses payment structure via PPVs, the submission of quarterly sales reports, and compliance with federal pricing for covered drugs.
    Lifecycle
    Title
    Type
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Currently viewing
    Solicitation
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Presolicitation
    Similar Opportunities
    6505--Buprenorphine Pre-solicitation notice
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Buprenorphine HCL/Naloxone HCL Sublingual Tablets, as outlined in the pre-solicitation notice VA797E26R0004. The procurement aims to establish a reliable supply source for federal healthcare programs, including the VA, DoD, IHS, and BOP, with a contract consisting of a one-year base period and four one-year option periods. These medications are critical for treating opioid dependence, and offerors must provide pricing for specific tablet strengths, comply with FDA manufacturing standards, and submit a Letter of Commitment from the manufacturer. Interested parties should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details, as compliance with various regulatory requirements and timely submission of quarterly sales reports will be essential for successful participation in this opportunity.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    DA01--New Contract - Polypharmacy (VA-26-00018584)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a new contract titled "Reducing Inappropriate Polypharmacy" to address medication management issues within the VA healthcare system. The procurement aims to develop and implement software solutions that will enhance program management, pilot phases, and sustainment of services, with an estimated total award amount of $47 million over a base period of six months and four one-year option periods. This initiative is critical for improving patient care and reducing the risks associated with polypharmacy among veterans. Interested parties must respond to the solicitation by January 14, 2026, at 10 AM Eastern Time, and can contact Contract Specialist Elena Juliano at elena.juliano@va.gov or 848-377-5194 for further information.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    DA01--Reducing Inappropriate Polypharmacy at the Department of Veterans Affairs
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a software solution aimed at reducing inappropriate polypharmacy among Veterans, as outlined in the presolicitation notice for Request for Information (RFI) number 36C10B25Q0550. The objective is to identify multi-drug interactions, optimize medication regimens, and support deprescribing through sophisticated, clinically-evidenced technology that adheres to VA's IT standards and ensures secure handling of patient data. This initiative is critical for improving medication management and clinical outcomes for Veterans, with a formal Request for Proposal (RFP) to be issued via Contracting Opportunities. Interested parties must ensure full registration in the System for Award Management (SAM.gov) and submit their responses by September 15, 2025, at 3 PM Eastern Time. For inquiries, contact Contract Specialist Elena Juliano at elena.juliano@va.gov or Contracting Officer John Vardouniotis at ioannis.vardouniotis@va.gov.
    Q301--Metabolomics and Lipidomic Pulmonary Study
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a contract titled "Q301--Metabolomics and Lipidomic Pulmonary Study," which has transitioned from a small business set-aside to full and open competition. The objective of this procurement is to conduct Metabolomics and Lipidomics testing on 185 human samples, which is crucial for advancing research in pulmonary health. The contract will span from January 20, 2026, to January 19, 2027, with all offers due by January 15, 2026, at 1:00 PM MST, and must be submitted via email to Contract Specialist Felicia L. Simpson at Felicia.Simpson@va.gov. Interested vendors are encouraged to review the solicitation documents thoroughly and ensure compliance with all requirements to facilitate a successful submission.
    Ondansetron Orally Disintegrating Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 MG and 8 MG tablets in various count bottles. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for treating nausea and vomiting in patients, and will be available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in September 2025, although the DLA reserves the right to issue it earlier or later. Interested parties should direct inquiries to Nancy Fernandez at nancy.fernandez@dla.mil or call 445-737-0713, and are encouraged to set up automated notifications for any changes to the solicitation through the DLA Bid Board System and Sam.Gov.
    Tucson CMOP COAL TAR 2% SHAMPOO 240ML AND MOISTURIZING LOTION
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Coal Tar 2% Shampoo and Moisturizing Lotion under Solicitation Number 36C77026Q0057, with a focus on pharmaceutical preparation manufacturing. This procurement is a Total Small Business Set-Aside and includes specific requirements such as the submission of a signed SF1449, a completed pricing schedule, and compliance with the Buy American Act. The products are essential for the treatment of various dermatological conditions among veterans, and all items must have a minimum expiration date of one year from the delivery date. Interested vendors should submit their quotes via email to Sarah Fry at sarah.fry2@va.gov by the extended deadline of January 12, 2026, at 4:00 PM CST.